Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities
High‐grade neuroendocrine carcinoma of gynecologic origin (NEC‐GYN) is a highly aggressive cancer that often affects young women. The clinical management of NEC‐GYN is typically extrapolated from its counterpart, small cell carcinoma of the lung (SCLC), but, unfortunately, available therapies have l...
Enregistré dans:
| Auteurs principaux: | Haider Mahdi, Amy Joehlin‐Price, Esther Elishaev, Afshin Dowlati, Ata Abbas |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ffae59a46950433a8f22dbd047b6eba3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
par: Emily Jiggens, et autres
Publié: (2021) -
Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review
par: Jason Cham, et autres
Publié: (2021) -
PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols
par: Natalya V. Maluchenko, et autres
Publié: (2021) -
Progress of Immune Checkpoint Inhibitors
in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
par: Haoqing CHEN, et autres
Publié: (2021) -
Efficacy and Safety of PD-1 Inhibitor Combined with Anlotinib on Advanced Neuroendocrine Carcinoma
par: YU Xuxu, et autres
Publié: (2021)